University of Basel, Vaccination, Organism, Basel, Switzerland, ETH Zurich

ROCKETVAX launched to develop a next-generation SARS-CoV-2 vaccine

On Nov 12, 2020
@eugen12 shared
RT @startuptickerCH: ROCKETVAX launched to develop a next-generation SARS-CoV-2 vaccine https://t.co/jTTCK1tVwi | The Swiss Startup News channel https://t.co/0hUtndt0Li https://t.co/qGXQtnmMpJ
Open

Founded as a subsidiary of Swiss Rockets AG, Basel based Rocketvax aims to leverage the DNA synthesis technology acquired from the ETH Zurich spin-off Gigabases Switzerland AG to develop next generation of SARS-CoV-2 virus vaccines. The rapid development of an effective and safe vaccine ...

www.startupticker.ch
On Nov 12, 2020
@eugen12 shared
RT @startuptickerCH: ROCKETVAX launched to develop a next-generation SARS-CoV-2 vaccine https://t.co/jTTCK1tVwi | The Swiss Startup News channel https://t.co/0hUtndt0Li https://t.co/qGXQtnmMpJ
Open

ROCKETVAX launched to develop a next-generation SARS-CoV-2 vaccine

ROCKETVAX launched to develop a next-generation SARS-CoV-2 vaccine

Founded as a subsidiary of Swiss Rockets AG, Basel based Rocketvax aims to leverage the DNA synthesis technology acquired from the ETH Zurich spin-off Gigabases Switzerland AG to develop ...

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

/PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. A Basel-based subsidiary,...

Sci-CH

Sci-CH

Science-Switzerland, August-September 2018 News on Swiss science, technology, education and innovation State Secretariat for Education, Research and Innovation SERI swissnex China ...

Swiss cautiously optimistic about Pfizer Covid-19 vaccine results

Swiss cautiously optimistic about Pfizer Covid-19 vaccine results

Federal health authorities see promising data on the Pfizer/BioNTech Covid-19 vaccine as a positive sign but warn it is too early to set a timetable.

Research into drugs and vaccines to combat Covid-19

Research into drugs and vaccines to combat Covid-19

As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. In addition, Professor Jeffrey Bode from the ...

Healthcare innovations gain traction with the DayOne Accelerator

Healthcare innovations gain traction with the DayOne Accelerator

Three innovative healthcare startups participate in the first round of the DayOne Accelerator. Faraz Oloumi from Aurteen, Chang Yun from Noul and Christian Vogler and Leo Gschwind from ...

Basel Area, Switzerland is the perfect location to do business in Europe

Basel Area, Switzerland is the perfect location to do business in Europe

Interview with Paul Eschmann, Director Asia at BaselArea.swiss, the official economic promotion organization of the Basel Area. He speaks about the strong life sciences cluster in the Basel ...

Researchers identify possible immune targets in the SARS-CoV-2 genome

Researchers identify possible immune targets in the SARS-CoV-2 genome

Otago researchers studying the COVID-19 virus (SARS-2) have discovered potential target points on its genome, which may contribute to future treatments for the virus.

What's In a Shot? Vaccine Types, Explained

What's In a Shot? Vaccine Types, Explained

In the race to find a vaccine against SARS-CoV-2, some contenders come from classic development methods. Others would be the first of their kind.

[BC]2 Basel Computational Biology Conference

[BC]2 Basel Computational Biology Conference

The [BC]2 Basel Computational Biology Conference is the key computational biology event in Switzerland uniting scientists working in a broad range of disciplines, including bioinformatics, ...

Credit Suisse Donates for Research

Credit Suisse Donates for Research

Credit Suisse has decided to sponsor a professorship in robotics at ETH Zurich. The bank hopes that the research conducted at the university in future can help its asset management make the ...

This coronavirus vaccine would be two breakthroughs in one

This coronavirus vaccine would be two breakthroughs in one

An mRNA Covid vaccine would be a world-first — representing not just a victory over the current virus, but a real step forward in the way we make vaccines

Swiss Sciences Night 2019

Swiss Sciences Night 2019

Swiss Sciences Night 2019 @ MIT Media Lab Have you ever considered studying or working in Switzerland? For a small country with roughly the population of New York City and the size of ...

In the Works – New AWS Region in Zurich, Switzerland

In the Works – New AWS Region in Zurich, Switzerland

Earlier this year, we launched the new AWS Region in Italy and have plans for three more AWS Regions in Indonesia, Japan, and Spain. Coming to Switzerland in 2022 Today, I’m happy to ...

Shot of hope: inside the race for a coronavirus vaccine

Shot of hope: inside the race for a coronavirus vaccine

Social distancing, self-isolation, city-wide lockdowns—they can only do so much. In order to stop Covid-19 in its tracks, we need a vaccine. So, how long will we have to wait?

ETH investing 200 million in Basel campus

ETH investing 200 million in Basel campus

On Thursday, the Swiss Federal Institute of Technology Zurich (ETH) held the groundbreaking ceremony for its new building on the Schällemätteli campus in Basel. It plans to invest 200 ...

‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast

‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast

The coronavirus is an easier target for potential vaccines than other pathogens, and a prime candidate for new cutting-edge vaccine platforms.